Baseline blood immunological profiling differentiates between Her2-breast cancer molecular subtypes: implications for immunomediated mechanisms of treatment response.

Onco Targets Ther · 2015 · PMC4655955 · PMID 26604799

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significanceP <0.06so close (0.05 < p ≤ 0.1)

19 – 21 Although we did not reach statistical significance in blood eosinophils count, the difference between the two cohorts of patients is clear ( P <0.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.